6.07
전일 마감가:
$6.21
열려 있는:
$6.18
하루 거래량:
3.29M
Relative Volume:
0.83
시가총액:
$1.87B
수익:
$493.67M
순이익/손실:
$-104.69M
주가수익비율:
-17.85
EPS:
-0.34
순현금흐름:
$-31.51M
1주 성능:
-2.41%
1개월 성능:
-19.28%
6개월 성능:
-39.18%
1년 성능:
-38.56%
아미쿠스 테라 Stock (FOLD) Company Profile
명칭
Amicus Therapeutics Inc
전화
(609) 662-2000
주소
47 HULFISH STREET, PRINCETON, NJ
FOLD을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
FOLD
Amicus Therapeutics Inc
|
6.07 | 1.92B | 493.67M | -104.69M | -31.51M | -0.34 |
![]()
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
![]()
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
아미쿠스 테라 Stock (FOLD) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-12-13 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2024-09-06 | 개시 | Jefferies | Buy |
2024-05-30 | 개시 | Wells Fargo | Overweight |
2024-05-14 | 업그레이드 | Guggenheim | Neutral → Buy |
2023-12-19 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2022-09-09 | 개시 | Morgan Stanley | Equal-Weight |
2022-04-13 | 재개 | Goldman | Neutral |
2022-01-14 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
2021-11-15 | 업그레이드 | Stifel | Hold → Buy |
2021-09-30 | 업그레이드 | JP Morgan | Neutral → Overweight |
2021-07-19 | 재개 | BTIG Research | Buy |
2021-05-27 | 개시 | Needham | Hold |
2021-05-21 | 개시 | UBS | Buy |
2021-04-14 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
2021-03-02 | 개시 | Stifel | Hold |
2021-02-12 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
2021-02-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2020-12-28 | 재개 | Cantor Fitzgerald | Overweight |
2020-12-10 | 다운그레이드 | Citigroup | Buy → Neutral |
2020-11-11 | 개시 | Berenberg | Hold |
2020-06-17 | 개시 | BTIG Research | Buy |
2020-02-04 | 재개 | Cantor Fitzgerald | Overweight |
2019-11-12 | 재확인 | H.C. Wainwright | Buy |
2019-06-17 | 개시 | H.C. Wainwright | Buy |
2019-06-05 | 재확인 | Cantor Fitzgerald | Overweight |
2019-04-05 | 개시 | Janney | Buy |
2019-01-30 | 개시 | Cantor Fitzgerald | Overweight |
2018-10-29 | 개시 | Citigroup | Neutral |
2018-08-17 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
2017-10-06 | 재개 | Goldman | Neutral |
2017-09-13 | 재확인 | Chardan Capital Markets | Buy |
2017-08-10 | 재확인 | Chardan Capital Markets | Buy |
2017-01-24 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
2016-05-18 | 개시 | BofA/Merrill | Buy |
2016-04-14 | 개시 | Robert W. Baird | Neutral |
2016-04-12 | 재확인 | Chardan Capital Markets | Buy |
2015-09-16 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
2015-06-16 | 재확인 | Chardan Capital Markets | Buy |
모두보기
아미쿠스 테라 주식(FOLD)의 최신 뉴스
Millennium Management LLC Has $4.31 Million Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Man Group plc Decreases Stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Amicus Therapeutics to Present at Upcoming Investor Conferences in June 2025 | FOLD Stock News - GuruFocus
Amicus Therapeutics to Present at Upcoming Investor Conferences in June 2025 - GlobeNewswire
Rare Disease Leader Amicus Therapeutics to Present Latest Updates at Major Healthcare Conferences - Stock Titan
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Sold by Voloridge Investment Management LLC - MarketBeat
Squarepoint Ops LLC Purchases 753,060 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Neo Ivy Capital Management Increases Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Woodline Partners LP Sells 726,952 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Purchased by Ameriprise Financial Inc. - Defense World
Pompe Disease Market: Epidemiology, Therapies, Companies, - openPR.com
Teza Capital Management LLC Sells 68,066 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Nuveen Asset Management LLC Purchases 159,139 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
297,830 Shares in Amicus Therapeutics, Inc. (NASDAQ:FOLD) Bought by Sovereign s Capital Management LLC - MarketBeat
Vestal Point Capital LP Acquires New Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Deutsche Bank AG Grows Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Rafferty Asset Management LLC Sells 73,883 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Enzyme Replacement Therapy Market Set to Witness Significant - openPR.com
Janus Henderson Group PLC Cuts Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Fabry Disease Market: Epidemiology, Therapies, Companies, - openPR.com
Prosight Management LP Buys Shares of 920,000 Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Acquired by D. E. Shaw & Co. Inc. - MarketBeat
Enzyme Replacement Therapy Market Generated Opportunities, - openPR.com
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Holdings Cut by BNP Paribas Financial Markets - MarketBeat
Orbimed Advisors LLC Increases Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Northern Trust Corp Has $31.76 Million Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Hudson Bay Capital Management LP Buys 379,800 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Batten Disease Treatment Market Size, Outlook 2031 by Key - openPR.com
Parkman Healthcare Partners LLC Has $7.39 Million Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Balyasny Asset Management L.P. Lowers Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Raymond James Financial Inc. Purchases Shares of 13,983 Amicus Therapeutics, Inc. (NASDAQ:FOLD) - Defense World
Is Amicus Therapeutics (FOLD) the Best Low Priced Biotech Stock to Buy Now? - Insider Monkey
Bayesian Capital Management LP Purchases 54,100 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
10 Best Low-Priced Biotech Stocks to Buy Now - Insider Monkey
Long Term Trading Analysis for (FOLD) - news.stocktradersdaily.com
아미쿠스 테라 (FOLD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):